TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk ...

Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer ...

Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for ...

When Jill decided to return to school to become an advanced practitioner, she sought my counsel. Going back to school after ...

HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.